NCT06157905View on ClinicalTrials.gov

Efficacy and Safety of Oral Tofacitinib in the Treatment of Alopecia Areata

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

August 6, 2022

Primary Completion Date

February 5, 2023

Study Completion Date

August 4, 2023

Conditions
Extensive Alopecia Areata
Interventions
DRUG

Oral Tofacitinib citrate

oral tofacitinib citrate was initiated at 5 mg twice daily after ruling out contraindications

Trial Locations (1)

54000

Services Institute of Medical Sciences, Lahore

All Listed Sponsors
lead

Services Institute of Medical Sciences, Pakistan

OTHER_GOV